Biosimilars and Bioanalytical Methods

This cluster of papers focuses on the immunogenicity of biosimilar therapeutics, including the validation of bioanalytical methods for assessing immunogenicity, the impact of manufacturing changes on immunogenicity, and the clinical outcomes and safety of switching from reference biologics to biosimilars. The use of dried blood spots for bioanalysis and the regulatory considerations for biosimilars are also prominent topics within this cluster.

Journals publishing in this area

1

Annals of the Rheumatic Diseases

Annals of the Rheumatic Diseases

ISSN 0003-49672,055 articles in this topic

364h-index

1.02Impact

72.9KArticles

1.2MCitations

2

Clinical Pharmacology & Therapeutics

ISSN 0009-9236398 articles in this topic

269h-index

2.99Impact

18.8KArticles

650.6KCitations

3

Nature Reviews Drug Discovery

ISSN 1474-1776212 articles in this topic

469h-index

11.63Impact

6.8KArticles

761.6KCitations